Robert Lisicki

Robert Lisicki

Former Chief Executive OfficeratZura Bio· In proxies 2023–2025

Pay in FY2025-74% from the year before · Zura Bio stock +109.6% the same year

Robert Lisicki was paid $1.7M in FY2025 (Dec), down 74%. Zura Bio stock rose 109.6% that year.

Pay$100 in the stock at the end of FY23 → $112
Pay is from the Summary Compensation Table of each Zura Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zura BioPublic company · 3 yr
    • Former Chief Executive Officer2023 – Present · 3 yrStock in role -86%
  2. Cadrenal Therapeutics, Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. CorHepta TherapeuticsPublic company · 2 yr
    • Director2023 – 2025 · 2 yrNo stock prices for these years
  4. Adiso TherapeuticsPublic company · 1 yr
    • Director2023 – 2024 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?